Skip to main content
logo
Lumos Diagnostics Holdings Limited (LDXHF)
OTCMKTS · Delayed Price · Currency is USD
0.1692
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

LDXHF Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
12.411.1310.5411.6318.85
Revenue Growth (YoY)
11.40%5.66%-9.41%-38.31%225.25%
Cost of Revenue
4.724.575.219.7610.25
Gross Profit
7.686.565.321.888.6
Selling, General & Admin
13.1111.511.6421.8918.36
Research & Development
0.110.070.251.331.24
Operating Expenses
15.7514.2215.5628.7819.6
Operating Income
-8.07-7.66-10.23-26.9-11
Interest Expense
-0.56-1.02-2.39-0.57-4.22
Interest & Investment Income
0.060.050.020-
Other Non Operating Income (Expenses)
1.44-02.04-0.020.19
EBT Excluding Unusual Items
-7.13-8.64-10.56-27.5-15.03
Merger & Restructuring Charges
----1.68-
Impairment of Goodwill
----1.02-
Gain (Loss) on Sale of Investments
----0.2-
Gain (Loss) on Sale of Assets
-0.050.041.590.02-
Asset Writedown
----15.35-
Pretax Income
-7.18-8.59-8.97-45.72-15.03
Net Income
-7.18-8.59-8.97-45.72-15.03
Net Income to Common
-7.18-8.59-8.97-45.72-15.03
Shares Outstanding (Basic)
680463235152-
Shares Outstanding (Diluted)
680463235152-
Shares Change (YoY)
46.85%97.23%54.17%--
EPS (Basic)
-0.01-0.02-0.04-0.30-
EPS (Diluted)
-0.01-0.02-0.04-0.30-
Free Cash Flow
-9.390.89-9.76-20.56-16.77
Free Cash Flow Per Share
-0.010.00-0.04-0.14-
Gross Margin
61.93%58.96%50.54%16.12%45.62%
Operating Margin
-65.07%-68.79%-97.13%-231.32%-58.35%
Profit Margin
-57.93%-77.19%-85.15%-393.16%-79.72%
Free Cash Flow Margin
-75.70%8.03%-92.67%-176.78%-88.96%
EBITDA
-7.46-6.97-9.07-25.67-10.69
EBITDA Margin
-60.19%-62.64%-86.10%-220.70%-56.70%
D&A For EBITDA
0.610.691.161.240.31
EBIT
-8.07-7.66-10.23-26.9-11
EBIT Margin
-65.07%-68.79%-97.13%-231.32%-58.35%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.